retatrutide mechanism triple agonist gip glp-1 glucagon receptor Beyond GLP- 1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based retatrutide mechanism triple agonist glp-1
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19

























![Phyrexian Cytoshaper [Unknown Event] BSL2021/VGP03EN](https://cdn.shopify.com/s/files/1/0745/9002/8087/files/mtg_placeholder_56b57204-cb1d-46c8-9832-49b725d5808b.png?v=1777303547)

